Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy

Abstract

Dual-specificity phosphatase-1 (DUSP1/MKP1), as a member of the threonine-tyrosine dual-specificity phosphatase family, was first found in cultured murine cells. The molecular mechanisms of DUSP1-mediated extracellular signal-regulated protein kinases (ERKs) dephosphorylation have been subsequently identified by studies using gene knockout mice and gene silencing technology. As a protein phosphatase, DUSP1 also downregulates p38 MAPKs and JNKs signaling through directly dephosphorylating threonine and tyrosine. It has been detected that DUSP1 is involved in various functions, including proliferation, differentiation, and apoptosis in normal cells. In various human cancers, abnormal expression of DUSP1 was observed which was associated with prognosis of tumor patients. Further studies have revealed its role in tumorigenesis and tumor progression. Besides, DUSP1 has been found to play a role in tumor chemotherapy, immunotherapy, and biotherapy. In this review, we will focus on the function and mechanism of DUSP1 in tumor cells and tumor treatment.

This review focuses on the function and mechanism of DUSP1 in tumor carcinogenesis and progression. DUSP1 promotes resistance to chemotherapy and radiation in various cancers and plays a role in tumor immunotherapy and biotherapy. Targeting DUSP1 could overcome the impaired efficacy caused by drug resistance and significantly improve current antitumor drugs' activity.

from Cancer via ola Kala on Inoreader http://ift.tt/1qM0sTN
via IFTTT